3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
4
Neoplasms
3
Cardiovascular Diseases
2
Urogenital Neoplasms
1
Smoldering Multiple Myeloma
1
Sarcoma
1
Psoriasis
1
Prostatic Neoplasms
1
Precancerous Conditions
1
Pain
1
Osteoarthritis
1
Monoclonal Gammopathy of Undetermined Significance
1
Melanoma
1
Lung Neoplasms
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hypertension
1
Head and Neck Neoplasms
1
Fatigue
1
Diabetes Mellitus
1
Depressive Disorder, Major
1
Depression
1
Colorectal Neoplasms
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Neoplasms, Male
1
Breast Carcinoma In Situ
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Arthralgia
1
Interventions
Methotrexate
8
Adalimumab
7
Etanercept
5
tocilizumab
4
Rituximab
4
tofacitinib
3
Abatacept
3
olokizumab
2
golimumab
2
Tumor Necrosis Factor Inhibitors
2
Antirheumatic Agents
2
upadacitinib
1
secukinumab
1
sarilumab
1
mavrilimumab
1
baricitinib
1
andecaliximab
1
Vitamin D
1
Vaccines
1
TACI receptor-IgG Fc fragment fusion protein
1
Syringes
1
Sulfasalazine
1
Saline Solution
1
Leflunomide
1
Hydroxychloroquine
1
Herpes Zoster Vaccine
1
Folic Acid
1
Fish Oils
1
Fatty Acids, Omega-3
1
Eicosapentaenoic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Arthritis, Rheumatoid
×
Fatty Acids, Omega-3
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts